Coronavirus disease 2026

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

Author

  • Yashika Choudhary is the Research Associate leading the Partnership Division at Pravasi Setu Foundation. Currently pursuing her MBA at Jawaharlal Nehru University and holding a Diploma in Development Studies from Dr. B.R. Ambedkar University Delhi, Yashika brings a results-driven approach and a strong foundation in economic analysis, strategic relationship-building, and event management. Her professional experience spans corporate affairs at Carlsberg, where she advanced sustainability initiatives and cross-sector collaboration, and human resources at ONGC, where she implemented data-driven solutions to enhance onboarding and organizational effectiveness.

    Yashika’s proven ability to connect with stakeholders, execute high-impact business initiatives, and foster dynamic partnerships makes her a valuable asset to the Foundation. As the head of the Partnership Division, she is dedicated to expanding PSF’s network through innovative collaborations with corporates, NGOs, and development sector organizations, aligning mutual strengths for social impact and sustainable growth. Her leadership and strategic vision support the Foundation’s mission to forge meaningful alliances that address the evolving needs of migrants and diaspora communities.

    View all posts